CTI Doubles Site Pool Using H1’s Real-World Data with Site Intelligence

“We were able to identify a number of new clinicians to approach. Several of them made their way onto the study, which is a very positive development. And I don’t know that we would’ve been able to achieve what we did without having an asset like H1 available to support this.”

– Earl Seltzer, Exec. Dir., Therapeutic Strategy & Innovation, CTI